Search

Rocky Mountain spotted fever (RMSF) is a life-threatening tick-borne disease documented in North, Central, and South America. In California, RMSF is rare; nonetheless, recent fatal cases highlight ecological cycles of the two genera of ticks, Dermacentor and Rhipicephalus, known to transmit the disease. These ticks occur in completely different habitats (sylvatic and peridomestic, respectively) resulting in different exposure risks for humans. This study summarizes the demographic, exposure, and clinical aspects associated with the last 40 years of reported RMSF cases to the California Department of Public Health (CDPH). Seventy-eight RMSF cases with onsets from 1980 to 2019 were reviewed. The incidence of RMSF has risen in the last 20 years from 0.04 cases per million to 0.07 cases per million (a two-fold increase in reports), though the percentage of cases that were confirmed dropped significantly from 72% to 25% of all reported cases. Notably, Hispanic/Latino populations saw the greatest rise in incidence. Cases of RMSF in California result from autochthonous and out-of-state exposures. During the last 20 years, more cases reported exposure in Southern California or Mexico than in the previous 20 years. The driver of these epidemiologic changes is likely the establishment and expansion of Rhipicephalus sanguineus sensu lato ticks in Southern California and on-going outbreaks of RMSF in northern Mexico. Analysis of available electronically reported clinical data from 2011 to 2019 showed that 57% of reported cases presented with serious illness requiring hospitalization with a 7% mortality. The difficulty in recognizing RMSF is due to a non-specific clinical presentation; however, querying patients on the potential of tick exposure in both sylvatic and peridomestic environments may facilitate appropriate testing and treatment.

Rickettsia philipii (type strain “Rickettsia 364D”), the etiologic agent of Pacific Coast tick fever (PCTF), is transmitted to people by the Pacific Coast tick, Dermacentor occidentalis. Following the first confirmed human case of PCTF in 2008, 13 additional human cases have been reported in California, more than half of which were pediatric cases. The most common features of PCTF are the presence of at least one necrotic lesion known as an eschar (100%), fever (85%), and headache (79%); four case-patients required hospitalization and four had multiple eschars. Findings presented here implicate the nymphal or larval stages of D. occidentalis as the primary vectors of R. philipii to people. Peak transmission risk from ticks to people occurs in late summer. Rickettsia philipii DNA was detected in D. occidentalis ticks from 15 of 37 California counties. Similarly, non-pathogenic Rickettsia rhipicephali DNA was detected in D. occidentalis in 29 of 38 counties with an average prevalence of 12.0% in adult ticks. In total, 5,601 ticks tested from 2009 through 2015 yielded an overall R. philipii infection prevalence of 2.1% in adults, 0.9% in nymphs and a minimum infection prevalence of 0.4% in larval pools. Although most human cases of PCTF have been reported from northern California, acarological surveillance suggests that R. philipii may occur throughout the distribution range of D. occidentalis., Author Summary Rickettsia philipii, a spotted fever group rickettsia, is the etiologic agent of Pacific Coast tick fever, an emerging tick-borne disease transmitted by the Pacific Coast tick (Dermacentor occidentalis). The Pacific Coast tick’s range, and thus potential for exposure to R. philipii, includes most of California, southern Oregon, and northern Baja California, Mexico. This study describes the clinical manifestations of the 14 human cases reported to date in California and the known acarological risk factors for encountering PCTF. While Rickettsia rickettsii, the agent of Rocky Mountain spotted fever (RMSF) is genetically similar to R. philipii, PCTF is a milder disease than RMSF; the two diseases share key clinical features such as headache and fever but differ in that PCTF presents with a localized eschar (necrotic wound) but without a petechial rash. Most case-patients have illness onset dates in the summer (peak: July and August) which is coincident with the activity period of immature D. occidentalis. Results from this study support the premise that larval and nymphal D. occidentalis are the vectors of PCTF to humans in California. While only three ticks have tested positive for R. rickettsii over decades of surveillance in California, the prevalence of R. philipii in D. occidentalis ticks averages 0.4% in larvae, 0.9% in nymphs, and 2.1% in adult ticks, indicating a higher risk of acquiring PCTF than RMSF statewide.